KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg), for a total of 80 mg per vial.
TB-500 (synthetic thymosin beta-4) is studied for its potential involvement in wound healing, angiogenesis, and tissue repair. BPC-157 exhibits regenerative properties, with preclinical evidence related to tendon, ligament, and muscle repair. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling. GHK-Cu is studied for its role in collagen synthesis, wound healing, and tissue regeneration.
This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
- Reconstitution: Add 3.0 mL of bacteriostatic water → approximately 26.7 mg/mL total concentration.
- Component concentrations: TB-500, BPC-157, and KPV each at approximately 3.33 mg/mL; GHK-Cu at approximately 16.7 mg/mL.
- Easy measuring: At a total concentration of 26.7 mg/mL, 1 unit = 0.01 mL ≈ 267 mcg total peptide on a U-100 insulin syringe.
- Storage: Lyophilized: store frozen at −20 °C (−4 °F). After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F). Avoid freeze–thaw cycles.
